Clinical

Cardiology: Efficacy of enoxaparin versus unfractionated heparin during angioplasty

Following a systematic review and meta-analysis, enoxaparin seems to be superior to unfractionated heparin in reducing mortality and bleeding outcomes during percutaneous coronary intervention and particularly in patients undergoing primary percutaneous coronary intervention for ST elevation myocardial infarction.

Twenty three trials representing 30,966 patients were identified.

Read more in the BMJ.

Bookmark and Share

Post a Comment

Enter this security code

Submit Comment for Moderation